Study #2018-0974
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes (MAGELLAN): A Prospective Open Label Study of The Use of Magseed Markers and Sentimag to Localize Axillary Lymph Nodes with Biopsy-Proven Metastases in Breast Cancer Patients
MD Anderson Study Status
Enrolling
Treatment Agent
Description
The purpose of this study is to provide prospective evidence that the use of Magseed/Sentimag in marking axillary lymph nodes and guiding surgical localization in patients with breast cancer following neo-adjuvant chemotherapy (NAC) is effective.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Breast Cancer;Axillary Lymph Nodes
Study phase:
Not applicable
Physician name:
Abigail Caudle
Department:
Breast Surgical Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.